MDAI · Spectral AI, Inc.

$1.58 +0.08 (+5.00%)

Market Cap

$50.28M

31.82M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue

$19.65M -33.6%

FY2025

Net Income

-$7.57M +50.1%

FY2025

Gross Margin

45.42% +0.6pp

FY2025

Operating Margin

-43.78% -21.5pp

FY2025

Diluted EPS

-$0.29 +65.9%

FY2025

Operating Cash Flow

-$9.92M -7.8%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2026 (G)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	-8.2%	—	—	$18.5M	$16.93M	$19.65M^G	$29.58M^G	$18.06M	$25.37M	—
Net Interest Income	—	—	—	—	$3.4M	—	—	—	$12.9M	$1.27M
Cost of Revenue	-9.6%	—	—	—	$9.15M	$10.73M	$16.31M	$10.18M	$14.53M	—
Gross Profit	-6.3%	—	—	—	$7.78M	$8.93M	$13.27M	$7.88M	$10.84M	—
Gross Margin	—	—	—	—	—	45.42%	44.87%	43.64%	42.72%	—
Research & Development	—	—	—	—	—	—	—	$15.1M	$16.5M	—
General & Administrative	+9.1%	—	—	—	$17.46M	$17.53M	$19.86M	$20.86M	$13.48M	$3.42M
Total Operating Expenses	+187.7%	—	—	—	$17.46M	$17.53M	$19.86M	—	$736K	—
Operating Income	—	—	—	—	-$9.68M	-$8.6M	-$6.58M	-$12.98M	-$2.65M	-$3.42M
Operating Margin	—	—	—	—	—	-43.78%	-22.25%	-71.91%	-10.43%	—
Interest Expense	—	—	—	—	—	$886K	-$14K	—	—	—
Interest Income	-19.9%	—	—	—	—	—	$14K	$172K	$3.16M	$27.24K
Other Non-Operating Income	—	—	—	—	-$4.27M	$1.04M	-$8.46M	-$7.86M	-$159K	—
Pretax Income	—	—	—	—	-$13.95M	-$7.56M	-$15.04M	-$20.84M	-$2.81M	-$2.15M
Income Tax	-53.0%	—	—	—	-$70K	$11K	$114K	$11K	$106K	$0
Net Income	—	—	—	—	-$13.88M	-$7.57M	-$15.16M	-$20.85M	-$2.91M	-$2.15M
Net Margin	—	—	—	—	—	-38.53%	-51.24%	-115.5%	-11.48%	—
Comprehensive Income	—	—	—	—	-$13.87M	-$7.53M	-$15.17M	-$20.84M	-$2.91M	—
EPS (Basic) USD/shares	—	—	—	—	—	-$0.29	-$0.85	-$1.48	-$0.22	—
EPS (Diluted) USD/shares	—	—	—	—	—	-$0.29	-$0.85	-$1.48	-$0.22	—
Shares Outstanding (Basic Avg) shares	+26.4%	—	—	—	—	26.52M	17.93M	14.09M	13.14M	—
Shares Outstanding (Diluted Avg) shares	+26.4%	—	—	—	—	26.52M	17.93M	14.09M	13.14M	—

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2022: $250.52M in buybacks.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

—

Peer median 1.21×

EV/EBIT

—

Peer median 18.54×

P/E (TTM)

—

Peer median 11.60×

Peer medians compare against the 78 similar-size Medical Devices companies (of 145 listed).

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component	FY2023	FY2022
BARDA Contracts	$17,027,000	$24,827,000
Other U.S. Governmental Authorities	$1,029,000	$541,000

Key facts CIK 1833498 CUSIP 84757T105 13F (30d) 6 filings 6 filers Visit website Investor relations